Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,936
Total Claims
$1.6M
Drug Cost
1,126
Beneficiaries
$1,386
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+230%
Opioid rate vs peers
7.4% vs 2.2% avg
-2%
Cost per patient vs peers
$1,386 vs $1,411 avg
-7%
Brand preference vs peers
9.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 230% above Internal Medicine peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
7.4%
Opioid Rate
1,400
Opioid Claims
$62K
Opioid Cost
11.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,870 claims · $1.2M
Generic: 16,972 claims · $386K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 160 | $173K |
| Semaglutide | 141 | $168K |
| Apixaban | 177 | $154K |
| Sitagliptin Phosphate | 60 | $61K |
| Lipase/Protease/Amylase | 26 | $57K |
| Rivaroxaban | 40 | $40K |
| Liraglutide | 14 | $35K |
| Insulin Lispro | 25 | $32K |
| Sitagliptin Phos/Metformin Hcl | 25 | $28K |
| Hydrocodone/Acetaminophen | 901 | $27K |
| Sacubitril/Valsartan | 33 | $23K |
| Insulin Detemir | 15 | $21K |
| Liraglutide | 21 | $19K |
| Insulin Aspart | 14 | $19K |
| Fluticasone Propionate | 47 | $19K |
Prescribing Profile
Patient Profile
76
Avg Age
55%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data